🔎 Trials Near Me

Gara Jalqabaatti › Dermatitis Atopic (Eczema) › California › Sacramento

Qorannoo klinikaalii Dermatitis Atopic (Eczema) Sacramento, CA keessatti

Qorannoo 8 Dermatitis Atopic (Eczema) f Sacramento fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 2
  • Novartis Investigative Site, Sacramento
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06947993

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 2
  • Integrative Skin Science and Research, Sacramento
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07599813

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Namoota walitti qabaa jiraSadarkaa 4
  • Integrative Skin Science and Research, Sacramento
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07560618

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 3
  • Integrative Skin Science and Research /ID# 265108, Sacramento
Umuriin 2 hanga 11 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06461897

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 3
  • Leo Pharma Investigational site, Sacramento
6 Months – 11 Years · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Namoota walitti qabaa jiraSadarkaa 3
  • Integrative Skin Science and Research /ID# 264537, Sacramento
Umuriin 18 hanga 63 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06389136

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 2
  • University of California, Davis Health, Department of Dermatology, Sacramento
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT06397911

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Namoota walitti qabaa jiraSadarkaa 2
  • Physioseq, LLC /ID# 267266, Sacramento
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 24-Ama-2025 · NCT06524635

Qorannoo Dermatitis Atopic (Eczema) magaalota biroo keessatti

Qorannoo biroo Sacramento keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.